Exact Mass: 523.2066884000001

Exact Mass Matches: 523.2066884000001

Found 27 metabolites which its exact mass value is equals to given mass value 523.2066884000001, within given mass tolerance error 1.6E-6 dalton. Try search metabolite list with more accurate mass tolerance error 3.2E-7 dalton.

Pralnacasan

N-{4-[(2-ethoxy-5-oxooxolan-3-yl)carbamoyl]-6,10-dioxo-hexahydro-1H-pyridazino[1,2-a][1,2]diazepin-7-yl}isoquinoline-1-carboxamide

C26H29N5O7 (523.2066884000001)


   

Asp Phe Gly Trp

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Phe Trp Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Gly Phe Trp

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Gly Trp Phe

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Trp Phe Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Trp Gly Phe

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-phenylethyl]carbamoyl}methyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Asp Gly Trp

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Asp Trp Gly

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Gly Asp Trp

(3S)-3-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Gly Trp Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-(1H-indol-3-yl)propanamido]butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Phe Trp Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Trp Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]acetamido}butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Gly Asp Phe Trp

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Gly Asp Trp Phe

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Gly Phe Asp Trp

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Gly Phe Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Gly Trp Asp Phe

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Gly Trp Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Trp Asp Phe Gly

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Trp Asp Gly Phe

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-[({[(1S)-1-carboxy-2-phenylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Trp Phe Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Trp Phe Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]acetamido}butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Trp Gly Asp Phe

(3S)-3-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Trp Gly Phe Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-phenylpropanamido]butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Pralnacasan

Pralnacasan

C26H29N5O7 (523.2066884000001)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

VX-740;Hmr 3480

VX-740;Hmr 3480

C26H29N5O7 (523.2066884000001)